¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"sex linked dominant inheritance"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • criss-cross inheritance
    ½ÊÀÚÀ¯Àü, À̼ºÀ¯Àü
  • cross inheritance
    ±³Â÷À¯Àü
  • cryptomeric inheritance
    ÀáÀçÀ¯Àü
  • cytoplasmic inheritance
    ¼¼Æ÷ÁúÀ¯Àü, ¸ð¼ºÀ¯Àü
  • extrachromosomal inheritance
    ¿°»öü¿ÜÀ¯Àü
  • holandric inheritance
    ³²¼ºÇÑÁ¤À¯Àü
  • hologynic inheritance
    ¿©¼ºÇÑÁ¤À¯Àü
  • homochronous inheritance
    µ¿½Ã±âÀ¯Àü
  • homotropic inheritance
    ÈÄõÇüÁúÀ¯Àü
  • inheritance
    À¯Àü
  • intermediate inheritance
    Áß°£À¯Àü
  • mitochondrial inheritance
    ¹ÌÅäÄܵ帮¾ÆÀ¯Àü
  • mosaic inheritance
    ¼¯ÀÓÀ¯Àü, ¸ðÀÚÀÌÅ©À¯Àü
  • multifactorial inheritance
    ¹µÀÎÀÚÀ¯Àü, ´ÙÀÎÀÚÀ¯Àü
  • maternal inheritance
    ¸ð¼ºÀ¯Àü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • cryptomeric inheritance
    ÀáÀçÀ¯Àü
  • cytoplasmic inheritance
    ¼¼Æ÷ÁúÀ¯Àü, ¸ð¼ºÀ¯Àü
  • extrachromosomal inheritance
    ¿°»öü¿ÜÀ¯Àü
  • holandric inheritance
    Çѳ²¼ºÀ¯Àü
  • hologenic inheritance
    ÇÑ¿©¼ºÀ¯Àü
  • homochronous inheritance
    µ¿½Ã±âÀ¯Àü
  • homotropic inheritance
    ÈÄõÇüÁúÀ¯Àü
  • inheritance
    À¯Àü
  • intermediate inheritance
    Áß°£À¯Àü
  • maternal inheritance
    ¸ð¼ºÀ¯Àü
  • mendelian inheritance
    ¸àµ¨À¯Àü
  • mosaic inheritance
    ¼¯ÀÓÀ¯Àü, ¸ðÀÚÀÌÅ©À¯Àü
  • multifactorial inheritance
    ¿©·¯ÀÎÀÚÀ¯Àü
  • nonmendelian inheritance
    ºñ¸àµ¨À¯Àü
  • particulate inheritance
    (¢¡mendelian inheritance) ¸àµ¨À¯Àü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • inheritance, extrachromosomal
    ¿°»öü¿Ü¼º À¯Àü
  • inheritance, maternal
    ¸ð¼ºÀ¯Àü
  • inheritance, multifactorial polygenic
    À¯Àü(ë¶îî), ´ÙÀÎÀÚ¼º(Òýì×í­àõ)ÀÇ À¯Àü(ë¶îî)
  • recessive inheritance
    ¿­¼ºÀ¯Àü(¡­ë¶îî).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • autosomal dominant disorders
    »ó¿°»öü ¿ì¼ºÁúȯ(ßÓæøßäô÷éÐàõòðü´)
  • autosomal dominant trait
    »ó¿°»öü¿ì¼ºÀ¯ÀüÇüÁú.
  • dominant
    ¿ì¼º(éÐàõ)(ÀÇ).
  • dominant
    ¿ì¼ºÀÇ
  • dominant autosomal gene
    ¿ì¼ºº¸Åë¿°»öüÀ¯ÀüÀÚ
  • dominant character
    ¿ì¼ºÇüÁú(¡­û¡òõ), Áö¹èÀû Ư¼º(ò¨ÛÕîÜ÷åàõ).
  • dominant complement
    ¿ì¼ºº¸Ã¼(¡­ÜÍô÷).
  • dominant cystoid macular dystrophy
    ¿ì¼º³¶Æ÷Ȳ¹ÝÀÌ¿µ¾ç(Áõ)
  • dominant dystrophic epidermolysis bullosa
    ¿ì¼º ÀÌ¿µ¾ç¼º ¼öÆ÷¼º Ç¥Çǹڸ®Áõ
  • dominant exudative vitreoretinopathy
    ¿ì¼º»ïÃâÀ¯¸®Ã¼¸Á¸·º¯Áõ
  • dominant eye
    ¿ì¼¼¾È
  • dominant gene
    ¿ì¼ºÀ¯ÀüÀÚ
  • dominant gene
    ¿ì¼ºÀ¯ÀüÀÚ(¡­ë¶îîí­).
  • dominant gene
    ¿ì¼ºÀ¯ÀüÀÚ(éÐàõë¶îîí­).
  • dominant hemisphere
    Áö¹è ´ë³ú¹Ý±¸
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
ADPKD autosomal dominant polycystic kidney disease
ADVIRC autosomal dominant vitreo-retinochoroidopathy
DEBS dominant epidermolysis bullosa simplex
DH daily habits; day hospital; dehydrocholate; dehydrogenase; delayed hypersensitivity; dermatitis herp...
DJOA dominant juvenile optic atrophy
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
DCR Dominant Control Region
DF Dominant follicles
DFIC Dominant frequency instability coefficient
DN Dominant negative
DF dominant frequency
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • male sex hormone
    ³²¼º È£¸£¸ó
  • matron : ±âÈ¥ ºÎÀÎ, ¿ä¸ð, º¸¸ð.

    mats sex

    ³²¼º
  • secondary sex characteristic
    ÀÌÂ÷ ¼ºÂ¡
  • sex cell
    ¼º ¼¼Æ÷
  • sex chromatin
    ¼º ¿°»ö ¼Òü, ¼º ¿°»öÁú
  • sex crime
    ¼º ¹üÁË
    °­°£, °­Á¦ ¿Ü¼³, °ø¿¬ ¿Ü¼³ ¹× ¿Ü¼³ ¹®¼­ ¹ÝÆ÷ µîÀ» ¸»ÇÑ´Ù.
  • sex diagnosis of fetus
    ÅÂ¾Æ ¼ºº° ÆÇÁ¤¹ý
    ¾ç¼ö Áß¿¡ ºÎÀ¯ÇÏ´Â ¼¼Æ÷¸¦ ¹è¾çÇØ ºÐ¼®ÇÑ´Ù.
  • sex differentiation
    ¼º ºÐÈ­
  • sex factor
    ¼º ÀÎÀÚ
  • sex hormone
    ¼º È£¸£¸ó
  • sex ratio
    ¼ººñ
  • sex transformation
    ¼º Àüȯ
    ¿¬¼Ò±â¿¡ ¼º¼±À» Á¦°ÅÇÏ¸é ³²³à Áß°£ °³Ã¼³ª À̼ºÀÇ Æ¯Â¡ÀÌ ¹ßÇöµÈ´Ù.
  • sex-influenced
    ¼º ¿µÇâÀÇ, Á¾¼ºÀÇ, ÇѼºÀÇ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
X-linked hypogammaglobulinaemia A congenital, X-linked recessive, primary immunodeficiency characterised by decreased numbers (or absence) of circulating B-lymphocytes with corresponding decrease in immunoglobulins of the five classes; associated with marked susceptibility to infection by pyogenic bacteria (notably, pneumococci and Haemophilus influenzae) beginning after loss of maternal antibodies.
X-linked hypogammaglobulinaemia with growth hormone deficiency, hypogammaglobulinaemia combined with a reduced number of B-cells; characterised by short stature, delayed puberty, and recurrent infections.
(05 Mar 2000)
X-linked ichthyosis A form of ichthyosis, due to 3-beta-hydroxysteroidsulfate sulfatase deficiency, that appears at birth or in early infancy and affects males; characterised by scaling predominantly on the neck and trunk but not on the palms and soles; histologically, there is hyperkeratosis, a granular layer in the epidermis, and normal epidermal cell turnover.
Synonym: steroid sulfatase deficiency.
(05 Mar 2000)
X-linked locus Any locus that in normal karyotypes is borne on the X chromosome.
(05 Mar 2000)
N-acetylated-alpha-linked acidic dipeptidase <enzyme> Chloride-dependent membrane bound metallopeptidase, most active with the endogenous neuropeptide n-acetyl-l-aspartyl-l-glutamate
Registry number: EC 3.4.13.-
Synonym: naaladase, glutamate carboxypeptidase II, prostate-specific membrane antigen, psm antigen
(26 Jun 1999)
ichthyosis, x-linked Chronic form of ichthyosis that is inherited as a sex-linked recessive trait carried on the x-chromosome and transmitted to the male offspring. It is characterised by severe scaling, especially on the extremities, and is associated with steroid sulfatase deficiency.
(12 Dec 1998)
enzyme-linked immunoabsorbent assay <investigation> The enzyme-linked immunoabsorbent assay is serologic test used as a general screening tool for the detection of antibodies to the HIV virus. Reported as positive or negative. Since false positive tests due occur (for example recent flu shot), positives will require further evaluation using the western blot. ELISA technology links an a measurable enzyme to either an antigen or antibody. In this way, it can then measure the presence of an antibody or an antigen in the bloodstream.
Acronym: ELISA
(27 Sep 1997)
enzyme-linked immunosorbent assay An immunoassay utilizing an antibody labelled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed.
(12 Dec 1998)
expression-linked copy <molecular biology> One of many different versions of the variable surface glycoprotein gene of the trypanosome (a parasitic protozoan which causes the disease African sleeping sickness), refers to whichever one of them is currently being expressed on the outer surface of the trypanosome.
(09 Oct 1997)
y-linked A gene on the Y chromosome. A y-linked gene is by necessity passed from father to son.
(12 Dec 1998)
Y-linked gene A gene located on a Y chromosome.
Synonym: holandric gene.
(05 Mar 2000)
Y-linked locus Any (haploid) locus that in normal karyotypes is borne on the Y chromosome. The known content is so far small.
(05 Mar 2000)
flavin-linked dehydrogenase <enzyme> A dehydrogenase that requires a riboflavin coenzyme to function properly.
(09 Oct 1997)
linked Said of two genetic loci that exhibit genetic linkage.
(05 Mar 2000)
linked gene <genetics> Genes and / or markers that are so closely associated on the chromosome that they are inherited together in 80% or more of cases.
(14 Oct 1997)
alternative inheritance Galton's term for an assumed form in which all the characters are derived from one parent.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á